Search Results
Site Search
New Tests Launched in March - Insights
In March 2019, Mayo Clinic Laboratories announced six new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
August 2023 - Clinical Chemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Chemistry.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - Insights
Divyanshu (Div) Dubey, M.B.B.S., describes Mayo Clinic Laboratories' new diagnostic test for CIDP, or chronic inflammatory demyelinating polyneuropathy. The new test detects two antibodies — NF155 and CNTN1 — to enhance diagnosis and guide...
erythrocytosis_evaluation_testing_algorithm.pdf
03/2023© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Erythrocytosis Evaluation Testing Algorithm Testing begins with: PVJAK / Polycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing...
myeloproliferative_neoplasm_a_diagnostic_approach_to_bone_marrow_evaluation.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/2023 Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation Clinical suspicion of myeloproliferative neoplasm Consistent with...
MCL - Renal Biopsy Patient Information - MC1235-45
MCL - Renal Biopsy Patient Information
The Prostate Health Index (PHI) in Prostate Cancer Risk Assessment - Insights
In this month’s “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to...
New Tests Launched in July - Insights
In July 2018, Mayo Medical Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in February - Insights
In February 2017, Mayo Medical Laboratories announced nine brand new tests along with numerous reference-value changes, obsolete tests, and algorithm changes.
MCL Erythrocytosis Patient Information MC1235177
MCL Erythrocytosis Patient Information Complete print Reset Form Erythrocytosis Patient Information Instructions accurate interpretation reporting results contingent
inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf
YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient with diarrhea when differential...
CPT codes and LOINC update: March 2022 - Insights
CPT Code updates posted to mayocliniclabs.com during the month of
New Tests Launched in March - Insights
In March 2018, Mayo Medical Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in May - Insights
In May 2017, Mayo Medical Laboratories announced eight brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Mayo Clinic Laboratories offers a robust menu of biomarker testing to assess liver disease related to nonalcoholic and alcoholic causes. These include FibroTest-ActiTest, a first-line screening assay that uses two diagnostic scores based on...
How an ex-NFL Linebacker Overcame His Greatest Opponent, Amyloidosis - Insights
Matt Millen, ex-pro NFL player, who played on four Super Bowl-winning teams underwent a nearly six-year medical journey in search for answers. Finally, he was diagnosed with amyloidosis using a new testing methodology at Mayo Clinic.
congenital-disorders-of-glycosylation-algorithm.pdf
Unexplained developmental delay, multisystemic disease with or without a neurologic component, multiple unexplained abnormalities of basic laboratory resultsa ■ CDGN - consistent with type I CDG (congenital disorder of glycosylation)...
Mayo Clinic develops and validates new antibody test to diagnose multiple sclerosis - Insights
Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research...
New Tests Launched in October - Insights
In October 2017, Mayo Medical Laboratories announced eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Autoimmune Axonal Evaluation [Test in Focus] - Insights
Divyanshu Dubey, M.B.B.S. gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be...
autoimmune-paraneoplastic-axonal-neuropathy-evaluation-algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2024 Autoimmune/Paraneoplastic Axonal Neuropathy Evaluation Algorithm ■ AGNA immunoblot ■ AGNA IFA Titer ■ GFAP antibody CBA ■ GFAP antibody IFA...
New tests launched in September - Insights
In September 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in February - Insights
In February 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Carbohydrate metabolism - Insights
Learn more about how Mayo Clinic Laboratories testing for carbohydrate metabolism can identify genetic variants and confirm diagnosis of these complex conditions.
MCL ThalassemiaHemoglobinopathy Patient Information MC123536
MCL ThalassemiaHemoglobinopathy Patient Information Complete print Thalassemia Hemoglobinopathy Patient Information Reset Form Instructions information requested important interpretation test
MCL Metabolic Hematology Patient Information MC1235251
MCL Metabolic Hematology Patient Information Complete print Reset Form Metabolic Hematology Patient Information Instructions information requested important interpretation test
MCL Second Trimester Maternal Screening AlphaFetoprotein Quad Screen Patient Information MC1235123
MCL Trimester Maternal Screening AlphaFetoprotein Quad Screen Patient Information Complete print Reset Form Trimester Maternal Screening Alpha Fetoprotein Quad Screen Patient Information Patient Information required Patient
Drawing the Line: The Rationale Behind Blood Tube Collection Order - Insights
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Brooke Katzman, Ph.D., to discuss the blood tube collection order.
New Tests Launched in August - Insights
In August 2020, Mayo Clinic Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in April - Insights
In April 2020, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in June - Insights
In June 2020, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in June - Insights
In June 2019, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in September - Insights
In September 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes. In addition to these new tests, the department also announced several test changes.
New Tests Launched in October - Insights
In October 2019, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in January - Insights
In January, Mayo Clinic Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in December - Insights
In December 2022, Mayo Clinic Laboratories announced seventy-eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
MCL - Chain of Custody Request - MC1944
MCL - Chain of Custody Request
MCL Molecular Genetics Biochemical Disorders Patient Information MC1235100
MCL Molecular Genetics Biochemical Disorders Patient Information Complete print Reset Form Molecular Genetics Biochemical Disorders Patient Information Instructions accurate interpretation reporting genetic results
For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.
neuromuscular_myopathy_testing_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 12/2022 Neuromuscular Myopathy Testing Algorithm Inherited myopathy suspected Adult onset proximal myopathy phenotype Specific (other) phenotypes ■...
hyperoxaluria_diagnostic_algorithm.pdf
10/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Adapted from “The Primary Hyperoxalurias: An Algorithm for Diagnosis,” American Journal of Nephrology 2005;25:154-160. By permission S. Karger AG,...
New Tests Launched in August - Insights
In August 2019, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
MCL Chromosomal Microarray Testing Prenatal Information MC1235196
MCL Chromosomal Microarray Testing Prenatal Information Complete print Chromosomal Microarray Prenatal Products Conception Information Reset Form Instructions accurate interpretation reporting
Oncology surveillance biomarker study enrolls patients and evaluates assay - Insights
Mayo Clinic Laboratories’ BioPharma Diagnostics team supports companies from discovery to post-market in advancing their precision medicine initiatives. In this collaboration example, learn how BioPharma Diagnostics helped a biotech company...
Insect-borne disease - Insights
Find out more about our targeted approach to testing for the various diseases carried by a number of different insect species.
Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy - Insights
In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses various clinical and paraclinical features of autoimmune encephalitis, autoimmune seizures, and...
Mayo Clinic Laboratory and Pathology Research Roundup: April 9 - Insights
This week’s Research Roundup highlights genetic evidence for early peritoneal spreading in pelvic high-grade serous cancer.
Neurofascin 155 IgG4 Antibody Test [Test in Focus] - Insights
John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of...
Direct immunofluorescence for autoimmune bullous diseases - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.